MaxCyte, Inc.
MXCTNASDAQHealthcareMedical Devices
As of Oct 15, 2026 close
- Market cap
- $138.87M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.64$1.87
- Volume (live)
- -
- Avg. volume (3M)
- 862.34K
MaxCyte (MXCT) Stock Price & Financial Analysis
MaxCyte Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.26 - $1.31 |
|---|---|
| 52-Week High | $1.87 |
| 52-Week Low | $0.64 |
| Open | $1.27 |
| Volume (last close) | 3.79M |
| Average Volume (3M) | 862.34K |
| Revenue (TTM) | 31.05M |
|---|---|
| Net Income (TTM) | -35.64M |
| Free Cash Flow (TTM) | -23.79M |
| EPS (TTM) | −$0.33 |
| Profit Margin | -114.77% |
| Operating Margin | -113.30% |
| Return on Equity (ROE) | -22.45% |
| Debt to Equity | 0.11 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 138.87M |
|---|---|
| Shares Outstanding | 106.82M |
| Price to Sales (P/S) | 4.47 |
| Price to Book (P/B) | 0.87 |
| EV/EBITDA | -4.90 |
| 50-Day MA | $1.21 |
|---|---|
| 200-Day MA | $1.06 |
| 1-Year Change | −26.55% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
MaxCyte at a Glance
As of the Oct 15, 2026 close, MaxCyte (MXCT) has a market capitalization of $138.87M. The stock trades at 4.5× sales. Over the trailing twelve months it lost $35.64M on revenue of $31.05M and burned $23.79M of free cash flow. Revenue fell 13.2% year over year.
As of its latest reported balance sheet, it holds $15.04M in cash and securities against $17.25M of debt, a net debt position of $2.21M.
MaxCyte does not currently pay a dividend.
The share price is down 26.6% over the past year. At $1.30 (the Oct 15, 2026 close) it sits within its 52-week range of $0.64 to $1.86, above its 200-day moving average of $1.06.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $4.00, 207.7% above the Oct 15, 2026 close.
Frequently Asked Questions About MaxCyte
What is the current stock price for MXCT?
As of the Oct 15, 2026 close, MXCT stock trades at $1.30. The 52-week range is $0.64–$1.87, with a day range of $1.25–$1.31.
What is the P/E ratio for MXCT?
The P/E ratio (Price-to-Earnings) for MXCT is shown in the Key Statistics section. This valuation metric helps compare MaxCyte, Inc. to industry peers.
Does MXCT pay dividends?
MaxCyte does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MXCT?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for MXCT is Buy. The average 12-month price target is $4.00, a 207.7% upside from the Oct 15, 2026 close of $1.30.
What is the market cap of MXCT?
As of the Oct 15, 2026 close, MaxCyte's market capitalization is $138.9M, classifying it as a micro-cap company. MaxCyte operates in the Healthcare sector within the Medical Devices industry.